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Abstract In this study, the in vitro and in vivo transfection
capacity of novel pH-sensitive sugar-based gemini surfac-
tants was investigated. In an aqueous environment at
physiological pH, these compounds form bilayer vesicles,
but they undergo a lamellar-to-micellar phase transition in
the endosomal pH range as a consequence of an increased
protonation state. In the same way, lipoplexes made with
these amphiphiles exhibit a lamellar morphology at
physiological pH and a non-lamellar phase at acidic pH.
In this study, we confirm that the gemini surfactants are
able to form complexes with plasmid DNA at physiological
pH and are able to transfect efficiently CHO cells in vitro.
Out of the five compounds tested here, two of these
amphiphiles, GS1 and GS2, led to 70% of transfected cells
with a good cell survival. These two compounds were
tested further for in vivo applications. Because of their
lamellar organisation, these lipoplexes exhibited a good
colloidal stability in salt and in serum at physiological pH
compatible with a prolonged stability in vivo. Indeed, when
injected intravenously to mice, these stable lipoplexes
apparently did not substantially accumulate, as inferred
from the observation that transfection of the lungs was not
detectable, as examined by in vivo bioluminescence. This
potential of avoiding ‘preliminary capture’ in the lungs
may, thus, be further exploited in developing devices for
specific targeting of gemini lipoplexes.
Keywords Transfection . Gene therapy . Cationic
liposomes . Gemini amphiphiles . pH Sensitive .
Bioluminescence
Abbreviations DNA: Deoxyribonucleic acid . lipolexes:
Complexes of DNA and cationic lipids . PEG: Poly
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Introduction
Although viral vectors display a highly effective gene
delivery and transfection efficacy in vivo, these systems,
nevertheless, suffer from several drawbacks, particularly
with regard to biohazard and safety [1, 2]. Consequently,
further research in the development of improved non-viral
vectors for therapeutic applications appears justified, as
these nanocarriers often show negligible immunogenicity.
In addition, the synthetic organic compounds, constituting
the carriers’ core, are readily chemically modified for target
purposes, while they can also accommodate a wide variety
of cargo ranging from small interfering RNA, plasmid
DNA, antisense oligodesoxynucleotides to proteins [3–10].
For decades, cationic lipids have been exploited as non-
viral DNA vectors (‘lipoplexes’), and have been shown to
give rise to good transfection efficiency in vitro; however,
they mostly failed to sustain this efficiency in vivo [11, 12].
One of the major hurdles for cationic lipid-based gene
delivery in vivo is the interaction of the lipoplexes with
serum and their uncontrolled and avid interaction with
cellular surfaces. Both electrostatic neutralization and the
presence of negatively charged proteins can affect the
colloidal stability of lipoplexes. It is commonly observed
for cationic entities that aggregation and interaction with
blood components result in a relatively enhanced gene
expression in the lungs, compared to other organs [13–16].
This is due to the fact that after intravenous injection,
lipoplexes first encounter the pulmonary capillary, where
the aggregated complexes are effectively retained [17].
PEGylation of cationic lipoplexes, relying on mixing of
lipids coupled with poly(ethylene glycol) (PEG-lipids)
with cationic lipids, is often used to minimize the
interaction with blood components, thereby reducing
aggregation and accumulation in the lungs [18, 19] and
concomitantly extending the circulation time. Indeed, we
and others have previously shown that PEG-lipids act via
stabilizing the lamellar phase of the lipoplex lipid phase
while this relatively hydrophilic coating to the lipoplex
shields it from interactions with protein or other blood
components [20–23]. Nevertheless, the presence of a
lamellar-phase stabilizing PEG coating can impair intra-
cellular gene delivery by frustrating endosomal release of
the cargo from cationic lipoplexes [21, 24]. Consequently,
strategies have been developed to trigger the timely
removal of this PEG coating to accomplish effective
cellular transfection. These strategies involve release of
either the PEG group via pH sensitive cleavage [25–27] or
the PEG-lipids as such, relying on acyl chain length-
dependent lipid exchange [28, 29].
However, the application of a novel class of pH-sensitive
sugar-based gemini surfactants may provide a simpler and
better programmable alternative for the use of a multi-
component PEGylated lipoplex for in vivo gene delivery.
Such gemini surfactants [30] do not require helper lipids, as
is the case for numerous cationic lipid-based systems, and,
most importantly, liposomes prepared from such surfac-
tants show a pH-dependent transition from the lamellar to a
micellar phase [30–32]. In fact, helper lipids, like DOPE,
frustrate this transition, thus causing a relative stabilization
of the bilayer structure and emphasizing the membrane
destabilizing micellar phase as a prerequisite for cytoplas-
mic DNA release [33]. The potential of the gemini
surfactant systems for gene delivery in vitro has been
demonstrated [34, 35].
The present work was undertaken to investigate the
mechanism of gemini-mediated transfection, i.e., whether
lipoplex destabilization follows a similar pH-sensitive
pattern as observed for liposomal bilayers. If so, we would
anticipate an enhanced stability of such complexes in vivo,
endosomal membrane destabilization being particularly
favored at mild acidic pH after cellular internalization. Our
data show that distinct gemini surfactants can be prepared,
which meet these criteria, showing no massive aggregation
and, hence, accumulation in lung tissue. The observed
transfection in vivo of the oral tract may potentially open
new applications for sugar-based gemini surfactants.
Materials and methods
Cell culture
CHO-K1 cells were grown in Dulbecco’s Modified Eagle
medium (Gibco) supplemented with 10% heat-inactivated
fetal calf serum, 2 mM L-glutamine, 50 U/ml penicillin, and
50 μg/ml streptomycin. Cells were maintained in a
humidified incubator at 37°C and 5% CO2 atmosphere.
Preparation of lipid vesicles
The sugar-based gemini surfactants were synthesized as
previously described [30, 31]. Liposomes were prepared
1 day before the experiment. Briefly, the appropriate
amount of lipids in methanol for a final concentration of
1 mM was put in a glass tube. The methanol was
evaporated under a stream of nitrogen and the lipid film
was further dried under vacuum for 4 h. Subsequently, the
film was resuspended in a buffer containing MES, HEPES,
and sodium acetate at 5 mM each, pH 6.5. The obtained
liposomal suspension was then freeze-thawed five times
and sonicated for 5 min in a bath sonicator.
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Transfection in vitro
The plasmid DNA used is pEGFP-N1 from Clontech
laboratories, which contains a luciferase reporter gene
inserted at the multiple cloning site. The plasmid, which
codes for both the Green Fluorescent Protein (GFP) and the
luciferase enzyme, was propagated in Escherichia coli
strains, and plasmid DNA was extracted using a GenElute
plasmid midi-prep kit from Sigma.
For transfection, cells were plated in six-well plate at a
density of 3×105 cells per well 18 h before transfection. For
one well, transfection medium was prepared as follows:
1 μg of plasmid was mixed with 25 nmol of gemini
surfactant vesicles, prepared as described above, in an
equal volume of serum-free medium. The medium was
supplemented with 25 mM HEPES and filtered after
adjustment at pH 7.0. The molar ratio of positive charges to
negative charges was 8 to 1. After 15 min of incubation at
room temperature, the lipoplexes were incubated with the
cells for 4 h at 37°C. Subsequently, the transfection
medium was removed and fresh medium containing 10%
fetal calf serum was added to the cells. Twenty-four hours
after initiating transfection, the cell medium was refreshed
again and after 48 h, the expression of the reporter gene
GFP was measured with a flow cytometer Epics Elite from
Beckman Coulter. Transfection efficiency is expressed as
the percentage of GFP-positive cells on the total of
surviving cells. Potential toxicity and cell survival were
estimated by counting the number of surviving cells on a
photograph of the cell monolayer and comparing it to
untreated cells.
Transfections carried out with lipofectamine 2000
reagent were done according to the manufacturer’s
specifications.
Cellular uptake of N-Rh-PE-labeled gemini lipoplexes
To determine the cellular uptake of lipoplex particles,
lipoplexes were prepared with lipid vesicles containing
0.1% N-(lissamine rhodamine B sulphonyl)phosphatidyl-
ethanolamine (N-Rh-PE; Avanti Polar Lipids). N-Rh-PE-
labeled lipoplexes were incubated with the cells exactly as
described for the ‘Transfection in vitro’ protocol. After 4 h
incubation at 37°C, the external fluorescence of non-
internalized lipoplexes was quenched with a 0.4% trypan
blue solution, thus allowing an accurate determination of
genuinely internalized complexes. Rhodamine-positive
cells were then sorted by FACS and the average fluores-
cence intensity per cell was measured.
Gel retardation assay for lipid/DNA interaction
A 0.5-μg plasmid was mixed with 12.5 nmol of gemini
surfactant vesicles in 5 mM MES/HEPES/sodium acetate
pH 7.4. The lipoplexes were then treated or not with Triton
X-100 (1% final concentration). Subsequently, after addi-
tion of 3 μl of 30% glycerol, the samples were loaded on a
1% agarose gel containing 1.25 mM ethidium bromide. A
voltage of 50 V was applied over the gel, immersed in a
1×TAE buffer, for 30 min. The DNA was then visualized
by UV illumination.
Small-angle X-ray scattering (SAXS)
To determine the lipoplex structure, SAXS measurements
of gemini lipoplexes were performed at 25°C using a
NanoStar device (Brucker AXS and Anton Paar) with a
ceramic fine-focus X-ray tube, operating in a point focus
mode. The tube was powered with a Kristalloflex K760
generator at 35 kV and 40 mA. The primary beam was
collimated using cross-coupled Göbel mirrors and a 0.1-mm
pinhole providing a CuKα radiation beam (wavelength
λ=0.154 nm) with a full-width at half-maximum of about
0.2 mm in diameter at the sample position. The sample-
detector distance was 0.24 m. The use of a Hi-Star position-
sensitive area detector (Siemens AXS) allowed recording
the scattering intensity in the q-range of 0.5 to 8.5 nm−1.
The scattering vector q is defined as q=(4π/λ) sin(θ/2),
where θ is the scattering angle. The measurements of the
samples, prepared by mixing gemini liposomes (2.4 μmol)
and plasmid DNA solution (100 μg, 8 to 1 molar charge
ratio ±), were performed in flame-sealed quartz capillaries
with a diameter of 1 mm. The measuring time was 9 h.
Determination and visualization of colloidal stability
of liposomes and lipoplexes
Turbidity of liposome and lipoplexes, as a measure of their
colloidal stability, was monitored as a function of time on a
Perkin Elmer LAMBDA 25 UV/Vis spectrometer at a
wavelength of 350 nm. The final concentration of lipids is
0.1 mM and the molar (±) charge ratio was 8 to 1. As a
reference, SAINT-2/DOPE (1:1) lipoplexes at a 2.5 to 1
molar (±) charge ratio were used [21, 36]. The kinetics
were measured as follows: vesicles were added to the
buffer at t=1 min and plasmid DNA, in the case of
lipoplexes, at t=5 min. To determine the effect of serum,
lipoplexes were made in salt and incubated for 15 min at
room temperature, after which serum was added to the final
concentration of 10 and 50%. For each compound, the
stability at five different conditions was tested, i.e., that of
surfactant vesicles, prepared in MES/HEPES/sodium ace-
tate buffer at pH 7 or in salt solution (HBS: 10 mMHEPES,
150 mM NaCl, pH 7), and that of lipoplexes, suspended in
HBS with or without addition of 10 or 50% serum. In all
cases, the initial kinetics of turbidity were monitored,
which leveled off after approximately 15 min.
Lipoplexes samples examined by light microscopy were
prepared as described for the turbidity measurements and
incubated at room temperature for 24 h. When applicable,
the final concentration of serum was 10%.
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Transfection in vivo
All animal studies were performed after receiving approval
of the Animal Experimentation Committee of the Uni-
versity of Groningen. Studies were performed on male
Balb/c nude mice (8 to 10 weeks of age). For in vivo
experiments, the plasmid DNA was freed from endotoxin,
which was done by extraction, using the EndoFree Plasmid
Maxi Kit from Qiagen. Some 200 μl of lipoplexes were
injected via the penile vein while anesthetized, and the
samples were prepared as follows: 40 μg of plasmid DNA
were mixed with 0.5 μmol of gemini surfactant in a 20%
sucrose solution. This sucrose solution was prepared in
HBS at pH 7.4. Twenty-four hours after injection and
10 min before measurement, the mice were anaesthetized
with 2.5% isoflurane gas in oxygen flow (1.5 l/min), and
kept at 37°C body temperature. Ten minutes before
imaging, mice were intraperitonealy injected with
D-luciferin (150 mg/ml, Xenogen, Alameda, CA, USA)
the substrate for luciferase. Luminescence emission was
visualized by a cooled charged coupled device (CCD)
camera, IVIS 100 system and Living Image Software
(Xenogen, Alameda CA, USA).
Results
Structure of the sugar-based gemini surfactants
Five different sugar-based gemini surfactants were em-
ployed in this study. Their structural characteristics are
shown in Fig. 1 and described in Table 1. Note that all
compounds contain (unsaturated) oleoyl hydrocarbon tails.
The head group is either a mannose or a glucose, which is
connected via either an ethylene oxide (EO) spacer [–(EO)2–
(CH2)2–] (GS1, GS2, and GS4) or a C6 aliphatic spacer
[–(CH2)6–] (GS3 and GS5).
The two amino moieties in the head groups of GS1, GS2,
GS3, and GS5 are weak bases and are fully protonated at
mild acidic pH, whereas the non-titratable amido linkage in
GS4 gives rise to a net neutral charge. Previously, it has
been shown [30, 31] that lipid vesicles prepared from
gemini surfactants such as GS1, GS2, GS3, and GS5 adopt
a micellar structure, whereas around pH 7, where these
gemini surfactants are monoprotonated, the bilayer struc-
ture is maintained in aqueous solution. Surfactant-mediated
gene delivery requires a membrane destabilization of the
lipoplexes within endosomal compartments, which allows
translocation of the gene into the cytosol via an as yet
poorly defined mechanism [37]. To investigate whether
such a destabilization could, thus, be triggered by a mild
acidic pH within endosomes after endocytic internaliza-
tion, subsequently giving rise to gene delivery and
expression, we next determined the in vitro transfection
efficiency of lipoplexes prepared from these gemini
surfactants.
In vitro transfection mediated by the sugar-based
gemini surfactants
Obviously, critical to transfection is the ability of the
cationic vector to efficiently form complexes with plasmid
DNA. Hence, this property was determined first for all five
sugar-based gemini surfactants, using a gel retardation
assay. Lipoplexes were prepared as described in Materials
and methods and samples were subjected to electrophoresis
on a 1% agarose gel. In this assay, non-entrapped DNAwill
migrate freely within the gel while complexed DNA will
only do so after lysis of the lipoplex with detergent. As
shown in Fig. 2a, for lipoplexes made with GS4, the
plasmid DNA migrates into the gel, irrespective of the
presence of detergent, whereas for all other complexes,
migration of free plasmid was only apparent after lipoplex
lysis.
These data imply that GS4, which is neutral at pH 7.4,
fails to engage in lipoplex assembly, in contrast to the










































































Fig. 1 Structure of the gemini surfactants (GS) 1 to 5
Table 1 Characteristics of the gemini surfactants 1 to 5
Compound Hydrocarbon tail Spacer Reduced sugar
GS1 Oleyl, C18:1 Δ9,
75% cis
–(EO)2–(CH2)2− Glucose
GS2 Oleyl, C18:1 Δ9,
75% cis
–(EO)2–(CH2)2− Mannose
GS3 Oleyl, C18:1 Δ9,
75% cis
–(CH2)6− Mannose
GS4 Oleyl, C18:1 Δ9,
100% cis
–(EO)2–(CH2)2− Glucose




which at similar conditions effectively complex DNA and
thus form lipoplexes. The same patterns were found when
lipoplexes, prepared at acidic pH 5.5 and 6.7, were
analyzed, whereas at pH 8.5 (where the amino groups are
no longer protonated), none of the gemini surfactants
formed complexes with plasmid DNA (data not shown).
These observations, thus, properly reflect the charge
behavior of the gemini surfactants as primary parameter
in lipoplex assembly, indicating that neither head group nor
spacer properties interfered with this propensity.
Before transfection, we then determined the efficiency of
interaction of either lipoplex with the cells, using N-Rh-PE
labeled lipoplexes. After 4 h of incubation with the cells,
non-bound lipoplexes were removed and the cells were
washed with trypan blue to quench the fluorescence of
attached complexes, non-quenched fluorescence thus
representing genuinely internalized complexes. As shown
in Fig. 2b, GS1, GS2, GS3, and GS5 lipoplexes are taken
up efficiently by the cells to very similar extents. As
expected, the neutral surfactant GS4, which also failed to
form lipoplexes, was not significantly internalized by the
cells. Moreover, fluorescent microscopy experiments were
carried out in the presence of free sugars (0.25 mM
mannose or glucose) and the extent of internalization was
identical with or without sugars (not shown), implying that
lipoplex charge rather than sugar specificity is the driving
force in the interaction of these gemini lipoplexes with the
cells.
Subsequently, CHO-K1 cells were transfected (at
pH 7.0) in vitro, using a plasmid containing the reporter
gene Green Fluorescent Protein (GFP). The transfection
efficiency was measured by counting the percentage of
GFP-positive cells by flow cytometry. To determine the
optimal conditions for transfection, lipoplexes were
prepared at various molar (±) charge ratios and cells were
transfected according to the protocol as described in
Materials and methods. In this manner, the highest
efficiency was determined at a charge ratio of 8 to 1 (±),
which was then used throughout this study, unless
indicated otherwise. In addition, in contrast to observations
made with other cationic systems in which the inclusion of
the so-called helper lipid DOPE may improve transfection,
an inhibition was observed in case of mixing the gemini
surfactants with this lipid (not shown; see Discussion).
Therefore, only the pure surfactants were examined for
their transfection capacity. Fig. 3a shows the FACS
analysis for untransfected cells (control) and cells trans-
fected with GS1 or GS5. GFP-positive cells correspond to
the cells in the area below the line marked by R2. Note that
this analysis is made on living cells only, a first sorting
allowing to separate cellular debris from normal cells.
Fig. 3b summarizes the results for all surfactants. As
anticipated, being incapable of effectively complexing
DNA, GS4 only led to 0.8% of GFP-positive cells. In
contrast, GS1, GS2, and GS3 displayed transfection
efficiencies of 73.9, 71.2, and 68.9%, respectively, of
GFP-positive cells. Interestingly, GS5 exhibited lower
transfection efficiency than the other gemini surfactants,
attaining a level of approximately 48% of GFP-positive
cells, which is very similar as the transfection efficiency
obtained with commercially available lipofectamine 2000
(LF2000).
Examination of the cell monolayer 48 h after transfection
(Fig. 3c) revealed that the gemini surfactants affected cell
survival to different extents. Commonly, more than 65% of
the cells survived when the cells had been transfected with
GS2. Cells transfected with GS1 showed a survival of
approximately 40% of the cells. However, GS3 and GS5,
both bearing aliphatic C6 spacers, showed the highest
toxicity with 21 and 31%, respectively, of cell survival
only. As a comparison, 52% of cells survived after
transfection with lipofectamine 2000. Taken together,
these data indicate that the transfection efficiency of the
various sugar-based gemini surfactants did not correlate
with head group specificity, as both GS1 and GS2
effectively transfected the cells, consistent with the inter-
action of the N-Rh-PE-labeled complexes with the cells.
Also, there seems to be no structural preference, as no
significant differences were seen in transfection efficiency
between GS2, which contains an ethylene oxide spacer,
and GS3, carrying the same head group, but a simple
aliphatic C6 spacer. However, the nature of the spacer
markedly affected cell survival, the ones containing an
ethylene oxide spacer displaying a relatively low toxicity.
Fig. 2 Analysis of lipoplex assembly of gemini surfactants and
cellular internalization of N-Rh-PE-labeled lipoplexes by CHO
cells. a Lipoplexes were made at pH 7.4 with all five sugar-based
gemini surfactants as indicated. The migration of free plasmid DNA
with (+) or without (−) prior treatment of the lipoplexes with the
Triton X-100 detergent was analyzed by agarose gel electrophoresis.
Note that for all surfactants, except GS4, plasmid DNA did not
migrate in the gel without treatment by a detergent. b N-Rh-PE-
labeled lipoplexes were incubated with the cells. After 4 h, external
fluorescence of non-internalized gemini lipoplexes was quenched
with a trypan blue solution and the intracellular Rhodamine
fluorescence as a reflection of internalized lipoplexes was measured
by FACS
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The following experiments were, therefore, carried out
with GS1 and GS2.
Colloidal stability of gemini surfactants lipoplexes
Lipoplexes that display a lamellar phase are colloidally
more stable in an aqueous environment, i.e., they are less
prone to aggregation than lipoplexes, which readily revert
to an inverted hexagonal HII phase. Particularly in vivo,
while circulating in the bloodstream, such properties are
highly desirable, in that destabilization should preferably
only take place once the complex has reached its site of
destination. Previous work demonstrated that GS1 lipo-
plexes, formed at physiological pH, like lipid vesicles of
the same compound, displays lamellar morphology with a
d spacing (d=2π/q001) of 59.8 Å [35].
To corroborate this observation for conditions that apply
to the present work, we analyzed by small angle X-ray
scattering (SAXS) the morphology of GS2 lipoplexes,
charge ratio 8:1 at physiological pH. The spectrum
obtained for GS2 lipoplexes is shown in Fig. 4 and reveals
two diffraction peaks at q=0.1063 Å−1and q=0.2130 Å−1.
The ratio between those q values of 1:2 is typical of a
lamellar morphology. The calculated spacing between the
two bilayers was d=59.1 Å. Consequently, both GS1 and
GS2 lipoplexes have a lamellar morphology at physiolog-
ical pH, when suspended in an aqueous environment.
However, in the blood circulation, the complexes will be
exposed to a higher ionic strength and serum proteins,
which in turn may also deteriorate colloidal stability.
To examine this effect, GS1 and GS2 lipid vesicles and
lipoplexes, respectively, were incubated in buffer of
physiological ionic strength and in 10 or 50% serum. As
a measure of colloidal stability, the initial kinetics (20 min)
in turbidity change were determined at pH 7 (Fig. 5a). GS1
and GS2 were compared to lipid vesicles and lipoplexes,
prepared from the dialkyl pyridinium surfactant SAINT-2/
DOPE (1:1). This system has been shown to transform
from a lamellar Lα phase to an inverted hexagonal phase
HII [36, 38], when transferred from water to a physiological
salt solution, a feature accompanied by a dramatic
Fig. 3 Gemini lipoplexes effi-
ciently transfect cells in vitro.
a CHO-K1 cells were transfec-
ted with lipoplexes containing a
plasmid coding for Green Fluo-
rescent Protein (GFP) as de-
scribed in the Materials and
methods section. The percentage
of GFP-positive cells as a mea-
sure of transfection efficiency
was determined by FACS for all
surfactants. FACS analysis of
untransfected cells (Control) and
cells transfected with GS1 or
GS5 are presented here. The R2
area is marked for non-trans-
fected cells (Control) and the
fraction of GFP-transfected cells
is determined from the shift into
the R2 region (area underneath
the line marked by R2). In b, the
percentage of transfected cells
for all surfactants (GS1, GS2,
GS3, GS4, and GS5) is sum-
marized. The transfection ob-
tained with the commercially
available Lipofectamine 2000 is
shown as reference (LF2000).
c Images of the cell monolayer
were taken 48 h after transfec-
tion and control cell and cells
transfected with GS2 and GS3
are shown (Control, GS2, and
GS3, respectively)
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enhancement in turbidity (Fig. 5a, tracks VI and VII; b,
+NaCl and pDNA). Interestingly, in contrast to a
pronounced aggregation of SAINT-2/DOPE liposomes
and lipoplexes, GS1 and GS2 liposomes and lipoplexes,
when transferred from a buffer of low ionic strength to a
HBS solution, exhibited a negligible increase in turbidity
when placed in HBS solution [Fig. 5a (I, II, and III); b
(−NaCl, +NaCl, and pDNA)]. This reflects the ability of
the HII forming SAINT-2/DOPE lipoplexes to rapidly
cluster [39], while, at the same conditions, gemini
lipoplexes do not aggregate. However, in the presence of
serum, GS1 and GS2 lipoplexes display a distinct degree of
aggregation, which, remarkably, appeared to be more
pronounced in 10% serum than in 50%, as reflected by an
increase of turbidity [Fig. 5a (IV), b (10 and 50% serum)],
although to a lesser extent than that observed for SAINT-2/
DOPE complexes.
The long-term effect of serum on the lipoplexes was
analyzed after 24 h by light microscopy (Fig. 6). It should
be noted, however, that at none of our transfection
conditions, the complexes were actually exposed to these
extreme conditions per se, but such extended incubation
conditions may be of help to further define the colloidal
stability of the complexes. Interestingly, after these
extended incubation periods, SAINT-2/DOPE lipoplexes
may grow, in the presence of salt only, to giant complexes
of up to 10 μm (Fig. 6d). Such clustering can be precluded
by ‘coating’ of the lipoplexes with serum proteins, as after
serum addition, the size of the lipoplexes stabilizes around
0.5 to 2 μm (Fig. 6c, c.f. also [40]).
As shown above for the turbidity measurements, the
behavior of GS1 and GS2 lipoplexes is opposite to that of
SAINT-2/DOPE lipoplexes. In salt, the gemini lipoplexes
do not aggregate, and after 24 h, no significant clustering of
particles could be observed. In 10% serum, however, the
gemini lipoplexes also aggregate after 24 h, leading to
particles of around 2 μm (Fig. 6a,b), implying long-term
changes that appear clearly different from those seen after
relatively short time intervals that are more reminiscent of
physiologically relevant conditions. Thus, after such
shorter time intervals the gemini surfactants show a
superior ‘stability’ over systems like those of the HII
phase adopting SAINT-2/DOPE system (Fig. 5a). This
relative stability could, thus, be exploited for in vivo
purposes in that the low level of aggregation, especially at
higher serum concentration, might allow the gemini
surfactant complexes to circulate for prolonged time
intervals rather than to accumulate readily in pulmonary
capillaries, shortly after administration.
Fig. 4 GS2 lipoplexes display a lamellar L phase at physiological
pH. GS2 lipoplexes were made at pH 7.3 as described in Materials
and methods and examined by SAXS. The diffraction pattern
revealed two peaks at q=0.1063 and 0.2130 (Å)−1 and the ratio of
1:2 between these two values is typical of a lamellar L phase. The
bilayer spacing (d) was 59.1 Å
Fig. 5 Effect of salt and serum on lipoplexes colloidal stability.
a Turbidity changes at 350 nm for GS1 and SAINT-2/DOPE
liposomes and lipoplexes was monitored as a function of time.
Traces of the kinetics for GS1 (I, II, III, and IV) and SAINT-2/DOPE
(V, VI, VII, and VIII) are shown and arrows indicate the time where
liposomes and plasmid DNAwere added. Kinetichs for GS2, similar
to the one of GS1, are not presented here. b The maximum turbidity
values reached for GS1, GS2, and SAINT-2/DOPE liposomes and
lipoplexes are summarized. “−NaCl” and “+NaCl” refer to the lipids
without plasmid DNAwith or without salt, respectively. The legend
“pDNA” indicates lipoplexes in salt solution (HBS); “10% Serum”
and “50% Serum” refer to lipoplexes that were made in HBS and
which were then incubated in the presence of either 10 or 50%
serum. The maximum turbidity values are indicated on the
histogram bars
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Transfection in vivo using GS1 and GS2 lipoplexes
To investigate the potential of GS1 and GS2 lipoplexes for
in vivo transfection purposes, a plasmid was used that
encodes the firefly luciferase enzyme, which emits light in
presence of its substrate luciferin, oxygen, ATP and
magnesium [41, 42], thus allowing in situ detection of
gene expression by luminescence imaging. Three groups of
three nude mice each were transfected using GS1
lipoplexes, GS2 lipoplexes or naked plasmid DNA.
Lipoplexes were injected intravenously in the penile
vein; each mouse received 0.5 μmol of lipids and 40 μg
of plasmid DNA or only naked plasmid DNA. Consecutive
to the injection of lipoplexes and naked DNA, the mice
experienced a mild discomfort, as shown by a reduced
mobility and the tendency to nest. Nevertheless, after 24 h,
all mice recovered perfectly and none of the animals died
after injection of either lipoplexes or naked DNA.
Expression of luciferase was examined 24 h after
injection of the lipoplexes using a cooled sensitive CCD
camera for detection of bioluminescence. As shown in
Fig. 7, administration of both GS1 (panel GS1) and GS2
(panel GS2) lipoplexes suggested expression of luciferase
in the living mice. For some mice a local expression at the
site of injection around the penile vein (Fig. 7; regions c
and e; panel GS1 and GS2) can be observed. However, the
expression of luciferase is mainly located in the lower
abdominal region of the mice (Fig. 7; regions a, b, and d;
panel GS1 and GS2).
Ex-vivo analysis of liver and spleen for luciferase
activity confirmed gene expression, mediated by both
formulations, in these organs, and in case of GS1 a
relatively enhanced expression was observed in the spleen
(data not shown). Consistent with the bioluminescence
image, neither GS1 nor GS2 lipoplexes led to significant
gene expression in the lungs. Some expression is found in
the mouth of the animal (Fig. 7; region f; panel GS1 and
GS2), which likely results from the animal licking the
injection site. Note, however, the absence of oral expres-
sion in mice treated with naked DNA (Fig. 7; panel
pDNA).
Discussion
The purpose of this work was to investigate the transfection
capacity of sugar-based gemini surfactants, which are
capable of undergoing a pH-triggered structural change,
i.e., from a lamellar phase at physiological pH to a non-
lamellar phase at mild acid pH. It was reasoned that this
property would convey colloidal stability to gemini
lipoplexes before cellular uptake, while exerting destabiliz-
ing properties necessary for gene delivery only after
internalization within mild acidic endosomal compart-
ments. By the same token, such a colloidal stability could
likely be exploited in vivo, avoiding massive aggregation
of these cationic lipids while in the circulation, which
would also preclude pulmonary capture, as often observed
for these systems [13–16].
Our data are consistent with this concept in that effective
transfection of those gemini surfactants capable of forming
DNA-bound lipoplexes was observed in vitro. Interest-
ingly, significant transfection was similarly observed in
vivo, showing gene expression in organs other than lungs,
as directly visualized by bioluminescence imaging. Thus,
the present systems should allow the possibility of better
defining potential correlations between mechanism(s) and
transfection efficiency as obtained in vitro vs in vivo.
Given the apparent colloidal stability of these particles in
the circulation, it should also become possible to exploit
them for targeting purposes.
This study shows that the sugar-based gemini surfactants
GS1, GS2, GS3, and GS5 can efficiently form complexes
with plasmid DNA and mediate transfection in vitro. The
effect of the head group, glucose vs mannose, or the effect
of the spacer, C6-alkyl vs ethylene oxide, does not appear
to modulate the level of transfection to a significant extent.
Indeed GS1, GS2, and GS3 all show a transfection
efficiency of approximately 70%. GS5 showed a somewhat
lower level of transfection (approximately 50%). This
could suggest that the combination of a C6-alkyl spacer
and a reduced glucose as head group are less favorable in
bringing about transfection, although the cellular uptake of
all gemini lipoplexes was very similar, as determined by
marking the complexes with a fluorescent lipid analogue
N-Rh-PE, allowing to distinguish binding from genuine
internalization of the lipoplexes.
Aside from a less efficient transfection, GS5 also
showed a relatively high toxicity, which appears to be
related to the nature of the spacer, as a similar negative
effect on cell survival was seen for GS3, which in turn
shares the aliphatic C6 spacer with GS5. Thus, GS1 and
Fig. 6 Effect of salt and serum on lipoplexes colloidal stability after
24 h. The lipoplexes were prepared as in Fig. 5. a GS1 lipoplexes
made in HBS and 10% serum was added. b GS2 lipoplexes in HBS,
10% serum was added. c SAINT-2/DOPE lipoplexes in HBS, 10%
serum added. d SAINT-2/DOPE lipoplexes in HBS no serum added.
The bar represents 40 μm
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GS2, both containing an ethylene oxide spacer, appear to
be the geminis of choice, as they displayed both a low
toxicity and relatively high transfection efficiency. Appar-
ently the nature of the head group, i.e., glucose vs mannose,
exerts little effect on lipoplex assembly, cell association,
and eventual transfection efficiency.
The molecular shape of the monoprotonated gemini
surfactant is such that it conveys a higher colloidal stability
than similar complexes formed by different cationic
amphiphiles. The preferred morphology of the gemini
lipoplex at neutral pH is lamellar (Fig. 4). In contrast,
cationic amphiphiles are often characterized by a packing
parameter (relatively small head group area vs relative
large hydrocarbon tail area) that leads to the formation of
lipoplexes organized in inverted phases [9]. The HII phase
has been widely recognized as promoting transfection in
vitro [21, 36, 37, 43]; however, as noted, such a colloidal
destabilization before reaching the target site could prove
disadvantageous, particularly upon their administration in
vivo. As lipoplexes with a lamellar organization are less
prone to aggregation than lipoplexes that have adopted an
inverted hexagonal phase, such a property would preclude
them from accumulating in the lungs, as commonly seen
for cationic delivery vehicles [15, 44, 45].
Indeed, both GS1 and GS2 lipoplexes are in a lamellar
phase at physiological pH, and, after injection in vivo,
show no transfection in the lungs. In this context, it is
relevant to note that in very recent work, applying a novel
and highly sensitive assay to monitor lipid phase changes
[46], we have determined that upon acidification, GS1 and
GS2 lipoplexes undergo a lamellar to a HI non-inverted
micellar transition and that this transition is impeded when
the HII (i.e., inverted) phase preferring DOPE is included
[33] (Wasungu et al., submitted for publication). These
data, thus, entirely explain the observation that DOPE
inhibits rather than promotes transfection of gemini
complexes.
The sensitivity to serum is an important issue when
applying cationic lipids for in vivo transfection. Two kinds
of effects of serum have been reported. One of these effects
is on the colloidal stability of lipoplexes. Indeed, the
presence of serum can cause aggregation and size increase
of the particles, which leads to pulmonary accumulation [9,
13, 47]. The second effect is a destabilization of the
lipoplexes structure and lipid/DNA interaction, which may
result in the destruction of the complexes [9]. This
sensitivity to serum can vary according to the type of
cationic lipids and the type of helper lipids. Thus, SAINT-
2/DOPE-mediated lipofection has been reported to be
serum resistant [48]. In the case of the widely used cationic
lipid DOTAP, it was shown to be sensitive to destabiliza-
tion by serum proteins when used in combination with
DOPE but not when used in combination with cholesterol
[13]. Likewise, the use of cholesterol as helper lipid with
DOTAP has also been shown to increase the delivery of
plasmid DNA to cells in vitro [49]. For DOTAP/DOPE, the
hexagonal structure of DOPE has been suggested to
facilitate penetration of serum proteins into the complex,
thus causing their disruption [9]. Clearly, in case of sugar-
based gemini surfactants, the lamellar organization of
lipoplexes not only provides an improved colloidal stabil-
ity but would also preclude complex disruption by
penetration of serum proteins.
In this study, we observed that serum added to gemini
surfactants lipoplexes provoked a mild aggregation
(Fig. 5b). As these lipoplexes have been shown to be
lamellar, this aggregation is not likely the result of
hydrophobic interactions between inverted hexagonal
particles (as noted above, a non-inverted structure is
maintained, also after exposure to mild acidic pH) but
Fig. 7 In vivo transfection mediated by GS1 and GS2. Male nude
mice were injected with GS1 or GS2 lipoplexes or with naked
plasmid DNA. The plasmid codes for the luciferase enzyme and its
activity is visualized by luminescence after injection of luciferin
using a cooled charged coupled device (CCD) camera
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rather the consequence of charge neutralization at the sur-
face of those lamellar lipoplexes. Interestingly, the extent of
lipoplex aggregation was inversely related to the serum
concentration, the aggregation being diminished at a higher
serum concentration. This effect has been reported before
for DOTAP/cholesterol lipoplexes [9], and was proposed to
be related to the possibility that a low concentration may
cause bridging of adjacent lipoplexes, whereas an enhanced
concentration may uniformly coat lipoplexes, thereby
preventing clustering.
A similar phenomenom could be at stake for the gemini
surfactants, as observed in the present study (Fig. 5b).
Consistent with this observation is the conspicuous
absence of extensive accumulation of lipoplexes in
pulmonary capillaries, which suggests that in vivo massive
clustering of gemini lipoplexes did not occur. This potential
of avoiding ‘preliminary capture’ could thus be further
exploited in developing devices for specific targeting of
gemini lipoplexes. Together, these data would also argue
strongly against the possibility that the lamellar phase, as
determined in vitro, would be converted to a non-lamellar
phase by serum proteins after injection into the circulation.
Moreover, such structural changes in circulating lipo- or
polyplexes have not been reported thus far, although
further work will be required to firmly exclude such a
possibility.
Interestingly, when compared to the absence of oral
expression in mice treated with naked DNA (Fig. 7, panel
pDNA), and yet the presence of expression on the injection
site (Fig. 7; regions b, c, and d, panel pDNA), it seems that
the gemini surfactants can play a protective role for the
DNA when present in the oral tract. We will, therefore,
further examine the interesting option of using the sugar-
based gemini surfactants for oral gene therapy.
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